There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The normal prostate and early-stage prostate cancers depend on androgens for growth and survival, and androgen ablation therapy causes them to regress. Cancers that are not cured by surgery eventually become androgen independent, rendering anti-androgen therapy ineffective. But how does androgen independence arise? We predict that understanding the pathways that lead to the development of androgen-independent prostate cancer will pave the way to effective therapies for these, at present, untreatable cancers.

Related collections

Author and article information

Journal

PubMed ID:: 11900250

DOI:: 10.1038/35094009

ScienceOpen disciplines: Chemistry

Keywords: Androgens,analysis,physiology,Growth Substances,Humans,Male,Mutation,Prostatic Neoplasms,etiology,therapy,Receptor Protein-Tyrosine Kinases,Receptors, Androgen,genetics

Data availability:

ScienceOpen disciplines: Chemistry

Keywords: Androgens, analysis, physiology, Growth Substances, Humans, Male, Mutation, Prostatic Neoplasms, etiology, therapy, Receptor Protein-Tyrosine Kinases, Receptors, Androgen, genetics

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.